TY - JOUR
T1 - Sex differences in anxiety and depression in children with attention deficit hyperactivity disorder
T2 - Investigating genetic liability and comorbidity
AU - Martin, Joanna
AU - Agha, Sharifah Shameem
AU - Eyre, Olga
AU - Riglin, Lucy
AU - Langley, Kate
AU - Hubbard, Leon
AU - Stergiakouli, Evie
AU - O'Donovan, Michael
AU - Thapar, Anita
AU - Andreassen, Ole A.
AU - Arnatkeviciute, Aurina
AU - Banaschewski, Tobias
AU - Bellgrove, Mark
AU - Borglum, Anders
AU - Buitelaar, Jan
AU - Burton, Christie
AU - Charach, Alice
AU - Corfield, Elizabeth
AU - Cormand, Bru
AU - Crosbie, Jennifer
AU - Demontis, Ditte
AU - Faraone, Steve V.
AU - Franke, Barbara
AU - Gizer, Ian
AU - Grevet, Eugenio H.
AU - Haavik, Jan
AU - Hakonarson, Hakon
AU - Hartman, Catharina
AU - Havdahl, Alexandra
AU - Hawi, Ziarih
AU - Hebebrand, Johannes
AU - Hinney, Anke
AU - Joober, Ridha
AU - Linnér, Richard Karlsson
AU - Klein, Marieke
AU - Kuntsi, Jonna
AU - Larsson, Henrik
AU - Lesch, Klaus P.
AU - Leung, Patrick W.L.
AU - Liao, Calwing
AU - Loo, Sandra
AU - Medland, Sarah
AU - Philipsen, Alexandra
AU - Ramos-Quiroga, Josep A.
AU - Reichborn-Kjennerud, Ted
AU - Reif, Andreas
AU - Ribases, Marta
AU - Salum, Giovanni
AU - Schachar, Russell
AU - Sengupta, Sarojini M.
AU - Psychiatric Genomics Consortium ADHD Working Group
N1 - Funding Information:
This research was funded in whole, or in part, by the Wellcome Trust [079711]. For the purpose of Open Access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission. The work was supported by funding from the Medical Research Council Center (grant no. MR/L010305/1), Health and Care Research Wales (grant no. 514032), Action Medical Research and Baily Thomas. We also acknowledge the support of the Supercomputing Wales project, which is part-funded by the European Regional Development Fund (ERDF) via Welsh Government. JM was supported by a Sêr Cymru II COFUND Fellowship from the Welsh Government (grant no. 663830 - CU189) and a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation (grant no. 27879). LR and AT were supported by the Wellcome Trust (204895/Z/16/Z). ES works in a unit that receives funding from the University of Bristol and the UK Medical Research Council (MC_UU_00011/1).
Funding Information:
This research was funded in whole, or in part, by the Wellcome Trust [079711]. For the purpose of Open Access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission. The work was supported by funding from the Medical Research Council Center (grant no. MR/L010305/1), Health and Care Research Wales (grant no. 514032), Action Medical Research and Baily Thomas. We also acknowledge the support of the Supercomputing Wales project, which is part-funded by the European Regional Development Fund (ERDF) via Welsh Government. JM was supported by a Sêr Cymru II COFUND Fellowship from the Welsh Government (grant no. 663830 - CU189) and a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation (grant no. 27879). LR and AT were supported by the Wellcome Trust (204895/Z/16/Z). ES works in a unit that receives funding from the University of Bristol and the UK Medical Research Council (MC_UU_00011/1). ALSPAC: We are extremely grateful to all the families who took part in the ALSPAC study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. GWAS data was generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. The UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and Joanna Martin will serve as guarantor for the contents of this article. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). With thanks to Dr Benjamin Neale for useful discussions related to the project. We would also like to acknowledge all other members of the Psychiatric Genomics Consortium ADHD Working Group not already listed: Jessica Agnew-Blais, Tony Altar, Richard Anney, Paul Arnold, Philip Asherson, Allison Ashley-Koch, Yorgos Athanasiadis, Ciebele Bandeira, Claiton Bau, Monica Bayes, Joseph Biederman, Isabell Brikell, Maria Jesus Arranz Calderun, Miguel Casas, Felecia Cerrato, Christine Cornforth, Alejandro Corsico, Soren Dalsgaard, Jurgen Deckert, Franziska Degenhardt, Alysa Doyle, Richard Ebstein, Josephine Elia, Juanita Gamble, Joel Gelernter, Michael Gill, Eugenio Horacio Grevet, Rachel Guerra, A.R. Hammerschlag, Amaia Hervas, Peter Holmans, Stefan Johansson, Lindsey Kent, Hyo-Won Kim, Gun Peggy Stromstad Knudsen, Paul Lichtenstein, Veera Manikandan, Meg Mariano, Nick Martin, Glaucia Chiyoko Akutagava Martins, Manuel Mattheisen, Jim McGough, Ana Miranda, Niels Peter Ole Mors, Preben Bo Mortensen, Nina Roth Mota, Fernando Mulas, Steve Nelson, Robert Oades, Pedro Pan, Julia Pinsonneault, Tinca Polderman, Danielle Posthuma, Herber Roeyers, Luis Rohde, Anna Rommel, Aribert Rothenberger, Paula Rovira, Cristina Sanchez, Andre Scherag, Susann Scherag, Joseph Sergeant, Pak Sham, Susan Smalley, Anna Starnawska, H.C. Steinhausen, Hans-Christoph Steinhausen, Patrick Sullivan, Alexandre Todorov, Raymond Walters, Yufeng Wang, Anne Wheeler, Nigel Williams, Li Yang, Tetyana Zayats, and Yanil Zhang.
Funding Information:
: We are extremely grateful to all the families who took part in the ALSPAC study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. GWAS data was generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. The UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and Joanna Martin will serve as guarantor for the contents of this article. A comprehensive list of grants funding is available on the ALSPAC website ( http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf ). ALSPAC
Funding Information:
Brain Behavior Research Foundation, Grant/Award Number: 27879; Health and Care Research Wales, Grant/Award Number: 514032; Medical Research Council, Grant/Award Number: MR/L010305/1; Wellcome Trust, Grant/Award Numbers: 079711, 204895/Z/16/Z; Welsh Government, Grant/Award Number: 663830-CU189; University of Bristol and the UK Medical Research Council, Grant/Award Number: MC_UU_00011/1 Funding information
Publisher Copyright:
© 2021 The Authors. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics published by Wiley Periodicals LLC.
PY - 2021/10/1
Y1 - 2021/10/1
N2 - It is unknown why attention deficit hyperactivity disorder (ADHD) is more common in males, whereas anxiety and depression show a female population excess. We tested the hypothesis that anxiety and depression risk alleles manifest as ADHD in males. We also tested whether anxiety and depression in children with ADHD show a different etiology to typical anxiety and depression and whether this differs by sex. The primary clinical ADHD sample consisted of 885 (14% female) children. Psychiatric symptoms were assessed using standardized interviews. Polygenic risk scores (PRS) were derived using large genetic studies. Replication samples included independent clinical ADHD samples (N = 3,794; 25.7% female) and broadly defined population ADHD samples (N = 995; 33.4% female). We did not identify sex differences in anxiety or depression PRS in children with ADHD. In the primary sample, anxiety PRS were associated with social and generalized anxiety in males, with evidence of a sex-by-PRS interaction for social anxiety. These results did not replicate in the broadly defined ADHD sample. Depression PRS were not associated with comorbid depression symptoms. The results suggest that anxiety and depression genetic risks are not more likely to lead to ADHD in males. Also, the evidence for shared etiology between anxiety symptoms in those with ADHD and typical anxiety was weak and needs replication.
AB - It is unknown why attention deficit hyperactivity disorder (ADHD) is more common in males, whereas anxiety and depression show a female population excess. We tested the hypothesis that anxiety and depression risk alleles manifest as ADHD in males. We also tested whether anxiety and depression in children with ADHD show a different etiology to typical anxiety and depression and whether this differs by sex. The primary clinical ADHD sample consisted of 885 (14% female) children. Psychiatric symptoms were assessed using standardized interviews. Polygenic risk scores (PRS) were derived using large genetic studies. Replication samples included independent clinical ADHD samples (N = 3,794; 25.7% female) and broadly defined population ADHD samples (N = 995; 33.4% female). We did not identify sex differences in anxiety or depression PRS in children with ADHD. In the primary sample, anxiety PRS were associated with social and generalized anxiety in males, with evidence of a sex-by-PRS interaction for social anxiety. These results did not replicate in the broadly defined ADHD sample. Depression PRS were not associated with comorbid depression symptoms. The results suggest that anxiety and depression genetic risks are not more likely to lead to ADHD in males. Also, the evidence for shared etiology between anxiety symptoms in those with ADHD and typical anxiety was weak and needs replication.
KW - ADHD
KW - ALSPAC
KW - anxiety disorders
KW - depression
KW - polygenic risk scores
KW - sex differences
U2 - 10.1002/ajmg.b.32842
DO - 10.1002/ajmg.b.32842
M3 - Article
SN - 1552-4841
VL - 186
SP - 412
EP - 422
JO - American Journal of Medical Genetics Part B-neuropsychiatric Genetics
JF - American Journal of Medical Genetics Part B-neuropsychiatric Genetics
IS - 7
ER -